IL13RA2 and Alzheimer disease: Using the “AD-mix,” one can observe epidermal features of AD including decreased expression of FLG, small proline rich proteins (SPRR2A) and increased expression of IL-13RA2 (one of the IL-13 receptor subunit), together with a weak increase of S100 calcium-binding protein A7 expression.